CGBIO Inc., Korea’s Regenerative Medicine company has recently announced a partnership agreement with NDR Medical Technology, a Singapore-based company, to introduce an Automated Needle Targeting...
Qynapse Inc. is a medical technology company that provides an AI-powered neuroimaging software platform for central nervous system (CNS) disorders. The company announced a rebrand...
A leading medical AI provider Lunit today announced that its AI for tissue analysis has been applied in a clinical trial for drug development, accurately...
Huadong Medicine (SZ.000963) and Insilico Medicine (“Insilico”), an end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the companies have entered into a co-development...
Keen Eye, a French health tech company, announced the launch of its new AI (Artificial Intelligence) web-based platform dedicated to accelerating clinical trials, following GCLP...
MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy....
The Quality Cancer Care Alliance Network (QCCA) partnered with ConcertAI, a market leader for Real-World Evidence (RWE) and enterprise AI Software-as-a-Service (SaaS) technology solutions for...
The Artificial Intelligence Based Medical Device Market Ecosystem is Expected to Grow at a CAGR of 25.7% by Forecast Year 2027. The medical devices market, which was valued at around US$...
The medical imaging industry is in the midst of large-scale transformation, largely driven by the advancements in technologies such as artificial intelligence (AI) and analytics,...
The global healthcare analytical testing services market size is expected to reach USD 23.9 billion by 2028 at a CAGR of 9.8% over the forecast period, according to a new...